Neurotherapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 7.4 | Q1 | 93.2% | 2.384 | Q1 | 96.6% |
| 2024 | 6.9 | Q1 | 93.5% | 2.063 | Q1 | 95.6% |
| 2023 | 5.6 | Q1 | 91.9% | 1.625 | Q1 | 93.6% |
| 2022 | 5.7 | Q1 | 87.3% | 1.461 | Q1 | 92.7% |
| 2021 | 6.1 | Q1 | 86.4% | 1.725 | Q1 | 94.6% |
| 2020 | — | — | 2.496 | Q1 | 96.9% | |
| 2019 | — | — | 2.230 | Q1 | 96.4% | |
| 2018 | — | — | 2.565 | Q1 | 96.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1878-7479
ISSN
1933-7213
region
Western Europe
coverage
2007-2026